Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Neurology

• Publication date

  2015-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00415-014-7535-0PMID 25311571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review

  2015cited by this paper
• Mechanisms of the placebo response.

  2013cited by this paper
• Nocebo as a potential confounding factor in clinical trials for Parkinson's disease treatment: a meta‐analysis

  2013cited by this paper
• Early onset absence epilepsy with onset in the first year of life: A multicenter cohort study

  2013cited by this paper
• Mechanisms and therapeutic implications of the placebo effect in neurological and psychiatric conditions.

  2013cited by this paper
• The adverse event profile of lacosamide: A systematic review and meta‐analysis of randomized controlled trials

  2013cited by this paper
• A meta-analytic approach to estimating nocebo effects in neuropathic pain trials

  2012cited by this paper
• The adverse event profile of pregabalin across different disorders: a meta-analysis

  2012cited by this paper
• What clinical trial designs have been used to test antiepileptic drugs and do we need to change them?

  2012cited by this paper
• Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis.

  2012cited by this paper
• Nocebo in fibromyalgia: meta‐analysis of placebo‐controlled clinical trials and implications for practice

  2012cited by this paper
• The placebo response: how words and rituals change the patient's brain.

  2011cited by this paper
• Factors determining response to antiepileptic drugs in randomized controlled trials. A systematic review and meta‐analysis

  2011cited by this paper
• The placebo response in clinical trials: more questions than answers

  2011cited by this paper
• Nocebo is the enemy, not placebo. A meta-analysis of reported side effects after placebo treatment in headaches

  2011cited by this paper
• The Nocebo Effect and Its Relevance for Clinical Practice

  2011cited by this paper
• A Systematic Review and Meta-analysis

  2010cited by this paper
• Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.

  2010cited by this paper
• Placebo responses in randomized trials of antiepileptic drugs.

  2010cited by this paper
• Nocebo effects in multiple sclerosis trials: a meta-analysis

  2010cited by this paper
• Ca-125: A Useful Marker to Distinguish Pulmonary Tuberculosis from Other Pulmonary Infections

  2009cited by this paper
• Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials

  2009cited by this paper
• A systematic review of adverse events in placebo groups of anti‐migraine clinical trials

  2009cited by this paper
• Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials.

  2008cited by this paper
• Physician Response to Patient Reports of Adverse Drug Effects

  2007cited by this paper
• How prior experience shapes placebo analgesia

  2006cited by this paper
• Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects.

  2006cited by this paper
• The Effects of Manipulating Expectations Through Placebo and Nocebo Administration on Gastric Tachyarrhythmia and Motion-Induced Nausea

  2006cited by this paper
• Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions.

  2004cited by this paper
• Drug-related information generates placebo and nocebo responses that modify the drug response.

  1999cited by this paper
• Experimenter effects in behavioral research

  1968cited by this paper

• European Headache Federation recommendations for placebo and nocebo terminology

  2020cites this paper
• Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials

  2019cites this paper
• A Meta-analysis of the Cortical Silent Period in Epilepsies.

  2015cites this paper
• Placebo and nocebo responses in drug trials of epilepsy.

  2015cites this paper